This is the authors' abstract. We don't add key points for this paper.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of auto-antibodies, immune complex formation, complement activation, and inflammatory damage to multiple organs. Renal involvement, commonly referred to as lupus nephritis (LN), represents one of the most clinically signif-icant manifestations of SLE because of its association with irreversible organ damage, increased treatment burden, and unfavorable long-term outcomes. Although renal and non-renal forms of SLE share common im-munopathological mechanisms, their clinical presentation, serological activity, and prognostic characteristics may differ substantially.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Mukhitdinova et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: